AGIOS PHARMACEUTICALS, INC. Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent
AGIOS PHARMACEUTICALS, INC. (AGIO) had Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent of $6.00 thousand as of 2013-12-31, per its 10-K filed 2014-03-18.
Discontinued › Notes › Compensation Related Costs
us-gaap:DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent · last filed 2014-03-18
- 2013-12-31: Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent $6.00K.
- 2013-06-30: Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent $10.00K.
- 2012-12-31: Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent $15.00K.
| Period end | Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent |
|---|---|
| 2013-12-31 | $6.00K 10-K · filed 2014-03-18 |
| 2013-06-30 | $10.00K 10-Q · filed 2013-09-05 |
| 2012-12-31 | $15.00K 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |